EIKN
Eikon Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$586.86M
P/E Ratio
—
EPS
$-6.18
Beta
—
52W High
$17.40
52W Low
$8.58
50-Day MA
$12.60
200-Day MA
$12.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics, Inc., is a clinical biopharmaceutical company in the United States. The company is headquartered in Millbrae, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-295.55M |
| Operating Margin | 0.00% |
| Return on Equity | -125.00% |
| Return on Assets | -36.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-286.47 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $54.14M |
| Float | $27.52M |
| % Insiders | 14.78% |
| % Institutions | 30.57% |
Analyst Ratings
Consensus ($25.60 target)
1
SellData last updated: 4/16/2026